Molina Healthcare Q3 2026 net income drops 52% year over year to $38 million

• Molina Healthcare’s third-quarter 2026 GAAP net income fell 52% year over year to $38 million, mainly due to higher consolidated MCR.
• Premium revenue declined year over year to $10.46 billion, reflecting lower Medicaid and Marketplace membership, partially offset by rate updates.
• Nine-month operating cash flow swung to an inflow of $629 million, mainly due to lower government receivable and payable settlements.
• The company will exit its traditional Medicare Advantage Prescription Drug product for 2027.
• Full-year 2026 guidance targets GAAP earnings of at least $2.38 per diluted share, with premium revenue unchanged at approximately $42 billion.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Molina Healthcare Inc. published the original content used to generate this news brief via Business Wire (Ref. ID: 202610211615BIZWIRE_USPR_____20261021_BW455974) on October 21, 2026, and is solely responsible for the information contained therein.